Urology is a branch of medicine that deals with the diagnosis and treatment of diseases affecting the urinary tract of males and females, reproductive organs of males, as well as kidneys, ureters, bladder and prostate.
Urology is a wide-ranging speciality and deals with the diagnosis and treatment of conditions such as genitourinary cancers including prostate cancer, cystinosis including nephropathic cystinosis as well as benign prostatic hyperplasia, erectile dysfunction and kidney transplantation for end-stage renal disease.
Featured Learning Zones
Related news and insights
AstraZeneca announced high-level results from Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant and clinically meaningful effect on its primary endpoint of a composite of worsening of renal function or risk of death (defined as a composite endpoint of greater than 50% sustained decline in estimated glomerular filtration rate (eGFR), onset of end stage kidney disease (ESKD) or cardiovascular (CV) or renal death) in adult patients with chronic kidney disease (CKD).
Mallinckrodt Plc announced that the Cardiovascular And Renal Drugs Advisory Committee of the U.S. FDA voted to recommend approval for its investigational agent terlipressin to treat adults with hepatorenal syndrome type 1 (HRS-1) (8 yes; 7 no).
Merck and Pfizer Inc.have announced that the FDA has approved the supplemental Biologics License Application (sBLA) for Bavencio (avelumab) for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy.